臓器移植用免疫抑制剤の世界市場レポート 2024年

臓器移植用免疫抑制剤市場規模は近年着実に成長しています。2023年の52億4,000万米ドルから2024年には54億2,000万米ドルへと、CAGR3.4％で拡大します。歴史的な期間における成長は、様々な要因によるものです。移植手術が顕著に増加し、ヘルスケアインフラの進歩や研究開発への多額の投資が後押ししました。世界の高齢化も、臓器移植の重要性と実行可能性に関する意識の高まりとともに、重要な役割を果たしました。

臓器移植用免疫抑制剤の市場規模は、今後数年間で安定した成長が見込まれます。2028年の年間平均成長率（CAGR）は3.8％で、62億9,000万米ドルに成長します。予測期間における成長は、いくつかの重要な要因によってもたらされると予想されます。新規治療法の出現、臓器不全の顕著な増加、個別化医療の出現、国際協力に支えられた世界ヘルスイニシアチブの影響などです。

臓器移植用免疫抑制剤市場は、臓器移植の需要増加により成長する見込みです。この救命外科手術は、損傷した臓器をドナーの健康な臓器と置き換えることを含みます。免疫抑制剤は移植後の臓器拒絶反応を防ぐために不可欠です。特筆すべきは、2021年、献体・移植に関する世界監視委員会（Global Observatory on Donation and Transplantation）は、年間11.3％の大幅な増加を報告し、144,302件の臓器移植が実施されたことです。この急増は、臓器移植用免疫抑制剤市場を推進する原動力を裏付けています。

老年人口の拡大は臓器移植用免疫抑制剤市場の成長を促進すると予測されています。免疫抑制剤は高齢の移植レシピエントにとって極めて重要であり、潜在的な副作用や薬物相互作用を軽減しながら拒絶反応を防ぐために、オーダーメイドの薬物レジメンが必要となります。世界保健機関（WHO）は、2030年までに世界の6人に1人が60歳以上の高齢者になり、その数は14億人に達し、2050年までに21億人に倍増すると予測しています。この人口動態の変化は、老年人口の拡大による市場の成長を裏付けています。

2023年の臓器移植用免疫抑制剤市場で最大の地域は北米でした。アジア太平洋は、臓器移植用免疫抑制剤の世界市場レポートにおいて、予測期間中に最も急成長する地域となる見込みです。臓器移植用免疫抑制剤市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の臓器移植用免疫抑制剤市場、薬剤クラス別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• カルシニューリン阻害剤
• 抗増殖剤
• mTOR阻害剤
• ステロイド
• その他
• 世界の臓器移植用免疫抑制剤市場、移植タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 心臓
• 腎臓
• 肝臓
• 肺
• 膵臓
• その他
• 世界の臓器移植用免疫抑制剤市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• 小売薬局
• オンライン薬局

第7章 地域および国の分析

• 世界の臓器移植用免疫抑制剤市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の臓器移植用免疫抑制剤市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 臓器移植用免疫抑制剤市場の競合情勢
• 臓器移植用免疫抑制剤市場の企業プロファイル
  • Astellas Pharma Inc.
  • F. Hoffmann-La Roche AG
  • Novartis AG
  • Accord Healthcare Limited
  • GlaxoSmithKline PLC

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Organ Transplant Immunosuppressant Drugs Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on organ transplant immunosuppressant drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for organ transplant immunosuppressant drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The organ transplant immunosuppressant drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Drug Class: Calcineurin Inhibitors; Antiproliferative Agents; mTOR Inhibitor; Steroids; Others Drug Classes
• 2) By Transplant Type: Heart; Kidney; Liver; Lung; Pancreas; Other Transplant Types
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: Astellas Pharma Inc.; F. Hoffmann-La Roche AG; Novartis AG; Accord Healthcare Limited; GlaxoSmithKline PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Organ transplant immunosuppressant drugs are crucial medications employed to curb the immune response in transplant recipients, mitigating the risk of rejection against the transplanted organ.

These drugs primarily fall into several classes calcineurin inhibitors, antiproliferative agents, mTOR inhibitors, steroids, and other miscellaneous classes. Calcineurin, an enzyme pivotal in T-cell activation, prompts the immune system to attack transplanted organs. Calcineurin inhibitors serve to prevent such rejection reactions in patients undergoing organ transplantation. These drugs find extensive use in heart, kidney, liver, lung, pancreas, and other organ transplants, and they are typically dispensed through hospital pharmacies, retail outlets, and online pharmacy platforms.

The organ transplant immunosuppressant drugs market research report is one of a series of new reports from The Business Research Company that provides organ transplant immunosuppressant drugs market statistics, including organ transplant immunosuppressant drugs industry global market size, regional shares, competitors with an organ transplant immunosuppressant drugs market share, detailed organ transplant immunosuppressant drugs market segments, market trends and opportunities, and any further data you may need to thrive in the organ transplant immunosuppressant drugs industry. This organ transplant immunosuppressant drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The organ transplant immunosuppressant drugs market size has grown steadily in recent years. It will grow from $5.24 billion in 2023 to $5.42 billion in 2024 at a compound annual growth rate (CAGR) of 3.4%. In the historic period, growth can be credited to various contributing factors. There was a notable increase in transplant procedures, bolstered by advancements in healthcare infrastructure and substantial investments in research and development. The global aging population also played a significant role, alongside heightened awareness regarding the importance and viability of organ transplantation.

The organ transplant immunosuppressant drugs market size is expected to see steady growth in the next few years. It will grow to $6.29 billion in 2028 at a compound annual growth rate (CAGR) of 3.8%. Anticipated growth in the forecast period is expected to result from several key factors. These include the emergence of novel therapies, a noticeable upsurge in organ failure incidences, the advent of personalized medicine, and the influence of global health initiatives, supported by international collaborations.

The organ transplant immunosuppressant drugs market is poised for growth due to the increasing demand for organ transplantation. This life-saving surgical procedure involves replacing damaged organs with healthy ones from donors. Immunosuppressant drugs are vital to prevent organ rejection post-transplantation. Notably, in 2021, the Global Observatory on Donation and Transplantation reported a significant 11.3% annual increase, with 144,302 organ transplants performed. This surge underscores the driving force propelling the organ transplant immunosuppressant drugs market.

The expanding geriatric population is projected to fuel the growth of the organ transplant immunosuppressant drugs market. Immunosuppressants are crucial for elderly transplant recipients, necessitating tailored drug regimens to prevent rejection while mitigating potential adverse effects and drug interactions. By 2030, the World Health Organization estimates that 1 in 6 people worldwide will be aged 60 or older, reaching 1.4 billion, doubling to 2.1 billion by 2050. This demographic shift underscores the market's growth driven by the expanding geriatric populace.

Product innovation emerges as a key trend shaping the organ transplant immunosuppressant drugs market. Major industry players are focused on developing innovative solutions such as combination therapies, enhancing immunosuppression efficacy while reducing side effects. For example, in July 2021, the FDA approved Prograf for use in combination with other immunosuppressants, expanding its application to prevent organ rejection in kidney, liver, or heart transplant recipients. This emphasis on combination therapies aligns with market demand for improved treatment options.

Market leaders in the organ transplant immunosuppressant drugs sector prioritize advanced drug solutions to augment their product portfolios and meet patient needs. Advanced medications aim to modulate the immune system in transplant recipients. For instance, in August 2023, Strides Pharma Science Ltd. secured USFDA approval for Cyclosporine Softgel Capsules USP (Modified), catering to kidney, liver, and heart transplant recipients. This approval reinforces Strides' position in the immunosuppressant market, complementing their existing offerings and enhancing patient care outcomes.

In September 2021, Sanofi S.A., a leading French pharmaceutical and healthcare enterprise, successfully acquired Kadmon Holdings for around $1.9 billion. This strategic move by Sanofi was driven by its goal to amplify its transplant-related portfolio and pipeline. The acquisition primarily aimed to incorporate Kadmon's immunosuppressant drug, Rezurock, recently approved by the US FDA for addressing chronic graft-versus-host disease (cGVHD). Kadmon Holdings Inc., a US-based biopharmaceutical company, specializes in the development and distribution of organ transplant immunosuppressant drugs.

Major companies operating in the organ transplant immunosuppressant drugs market report are Astellas Pharma Inc., F. Hoffmann-La Roche AG, Novartis AG, Accord Healthcare Limited, GlaxoSmithKline PLC, Pfizer Inc., Sanofi S.A., Alsachim a Shimadzu Group Company, Neovii Pharmaceuticals AG, Zydus Lifesciences Limited, Dr. Reddy's Laboratories Ltd., Lupin Limited, Mylan N.V., Strides Pharma Global Pte Ltd., Asahi Kasei Corporation, Bristol-Myers Squibb Company, GSK PLC, Veloxis Pharmaceuticals A/S, Viatris Inc., Janssen Pharmaceuticals Inc., AbbVie Inc., Hansa Biopharma AB, Wockhardt Ltd., Glenmark Pharmaceuticals Ltd., Biocon Ltd., Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd., Cipla Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Intas Pharmaceuticals Limited, Alkem Laboratories Limited, Torrent Pharmaceuticals Limited

North America was the largest region in the organ transplant immunosuppressant drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global organ transplant immunosuppressant drugs market report during the forecast period. The regions covered in the organ transplant immunosuppressant drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the organ transplant immunosuppressant drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The organ transplant immunosuppressant drugs market consists of sales of drugs such asteroid-sparing immunosuppressants, prednisone, antineoplastics, monoclonal antibody drug, and immunosuppressive agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Organ Transplant Immunosuppressant Drugs Market Characteristics

3. Organ Transplant Immunosuppressant Drugs Market Trends And Strategies

4. Organ Transplant Immunosuppressant Drugs Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Organ Transplant Immunosuppressant Drugs Market Size and Growth

• 5.1. Global Organ Transplant Immunosuppressant Drugs Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Organ Transplant Immunosuppressant Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Organ Transplant Immunosuppressant Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Organ Transplant Immunosuppressant Drugs Market Segmentation

• 6.1. Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Calcineurin Inhibitors
• Antiproliferative Agents
• mTOR Inhibitor
• Steroids
• Others Drug Classes
• 6.2. Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Heart
• Kidney
• Liver
• Lung
• Pancreas
• Other Transplant Types
• 6.3. Global Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

7. Organ Transplant Immunosuppressant Drugs Market Regional And Country Analysis

• 7.1. Global Organ Transplant Immunosuppressant Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Organ Transplant Immunosuppressant Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market

• 8.1. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Organ Transplant Immunosuppressant Drugs Market

• 9.1. China Organ Transplant Immunosuppressant Drugs Market Overview
• 9.2. China Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Organ Transplant Immunosuppressant Drugs Market

• 10.1. India Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Organ Transplant Immunosuppressant Drugs Market

• 11.1. Japan Organ Transplant Immunosuppressant Drugs Market Overview
• 11.2. Japan Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Organ Transplant Immunosuppressant Drugs Market

• 12.1. Australia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Organ Transplant Immunosuppressant Drugs Market

• 13.1. Indonesia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Organ Transplant Immunosuppressant Drugs Market

• 14.1. South Korea Organ Transplant Immunosuppressant Drugs Market Overview
• 14.2. South Korea Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Organ Transplant Immunosuppressant Drugs Market

• 15.1. Western Europe Organ Transplant Immunosuppressant Drugs Market Overview
• 15.2. Western Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Organ Transplant Immunosuppressant Drugs Market

• 16.1. UK Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Organ Transplant Immunosuppressant Drugs Market

• 17.1. Germany Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Organ Transplant Immunosuppressant Drugs Market

• 18.1. France Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Organ Transplant Immunosuppressant Drugs Market

• 19.1. Italy Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Organ Transplant Immunosuppressant Drugs Market

• 20.1. Spain Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Organ Transplant Immunosuppressant Drugs Market

• 21.1. Eastern Europe Organ Transplant Immunosuppressant Drugs Market Overview
• 21.2. Eastern Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Organ Transplant Immunosuppressant Drugs Market

• 22.1. Russia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Organ Transplant Immunosuppressant Drugs Market

• 23.1. North America Organ Transplant Immunosuppressant Drugs Market Overview
• 23.2. North America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Organ Transplant Immunosuppressant Drugs Market

• 24.1. USA Organ Transplant Immunosuppressant Drugs Market Overview
• 24.2. USA Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Organ Transplant Immunosuppressant Drugs Market

• 25.1. Canada Organ Transplant Immunosuppressant Drugs Market Overview
• 25.2. Canada Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Organ Transplant Immunosuppressant Drugs Market

• 26.1. South America Organ Transplant Immunosuppressant Drugs Market Overview
• 26.2. South America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Organ Transplant Immunosuppressant Drugs Market

• 27.1. Brazil Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Organ Transplant Immunosuppressant Drugs Market

• 28.1. Middle East Organ Transplant Immunosuppressant Drugs Market Overview
• 28.2. Middle East Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Organ Transplant Immunosuppressant Drugs Market

• 29.1. Africa Organ Transplant Immunosuppressant Drugs Market Overview
• 29.2. Africa Organ Transplant Immunosuppressant Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Organ Transplant Immunosuppressant Drugs Market, Segmentation By Transplant Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Organ Transplant Immunosuppressant Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Organ Transplant Immunosuppressant Drugs Market Competitive Landscape And Company Profiles

• 30.1. Organ Transplant Immunosuppressant Drugs Market Competitive Landscape
• 30.2. Organ Transplant Immunosuppressant Drugs Market Company Profiles
  • 30.2.1. Astellas Pharma Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. F. Hoffmann-La Roche AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Novartis AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Accord Healthcare Limited
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. GlaxoSmithKline PLC
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Organ Transplant Immunosuppressant Drugs Market Competitive Benchmarking

32. Global Organ Transplant Immunosuppressant Drugs Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Organ Transplant Immunosuppressant Drugs Market

34. Organ Transplant Immunosuppressant Drugs Market Future Outlook and Potential Analysis

• 34.1 Organ Transplant Immunosuppressant Drugs Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Organ Transplant Immunosuppressant Drugs Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Organ Transplant Immunosuppressant Drugs Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer